Liproxstatin-1: Potent Ferroptosis Inhibitor with IC50 22 nM

Executive Summary: Liproxstatin-1 is a small molecule inhibitor that selectively suppresses ferroptosis, an iron-dependent cell death pathway characterized by lipid peroxidation (Yang et al., 2025). It demonstrates nanomolar potency (IC50 ≈ 22 nM) in cellular models, especially those deficient in glutathione peroxidase 4 (GPX4) (APExBIO technical datasheet). Liproxstatin-1's mechanism involves direct inhibition of lipid peroxide accumulation, preventing membrane damage. In vivo, it prolongs survival in renal injury models and reduces hepatic ischemia/reperfusion damage (Yang et al., 2025). The compound is insoluble in water but highly soluble in DMSO and ethanol under specific conditions, requiring careful storage and handling (APExBIO).

Biological Rationale

Ferroptosis is a regulated cell death process dependent on iron and marked by the accumulation of lipid peroxides in cellular membranes (Yang et al., 2025). Unlike apoptosis or necrosis, ferroptosis is initiated by imbalances in redox homeostasis, especially when antioxidant systems such as GPX4 are compromised. The buildup of oxidized polyunsaturated phospholipids (oxPUFA-PLs) disrupts membrane integrity and is central to ferroptotic execution. Recent studies have highlighted that the failure to clear these lipid peroxides leads to membrane collapse and immune activation, as seen in TMEM16F-deficient tumor models (Yang et al., 2025). Targeting this pathway has implications for understanding tissue injury, neurodegeneration, and cancer biology (Liproxstatin-1: Strategic Deployment of a Potent Ferropto...; extends on the mechanistic depth by focusing on membrane events).

Mechanism of Action of Liproxstatin-1

Liproxstatin-1 acts as a selective inhibitor of ferroptosis by blocking the propagation and accumulation of lipid peroxides in cell membranes. Its nanomolar potency (IC50 ≈ 22 nM) is established in GPX4-deficient cell lines exposed to ferroptosis inducers such as RSL3 (APExBIO). Mechanistically, Liproxstatin-1 interrupts the lipid peroxidation pathway downstream of iron-induced ROS generation, preserving membrane integrity. This action prevents the formation of nanopores and membrane rupture, hallmarks of ferroptotic cell death (Yang et al., 2025). In contrast to antioxidants that scavenge free radicals globally, Liproxstatin-1 specifically targets lipid peroxide accumulation, making it an indispensable probe for dissecting late-stage ferroptosis events (Harnessing Liproxstatin-1 for Next-Generation Ferroptosis...; this article updates translational application scenarios).

Evidence & Benchmarks

• Liproxstatin-1 inhibits ferroptosis with an IC50 of approximately 22 nM in GPX4-deficient cellular models (APExBIO, product page).
• It prevents RSL3-induced lipid peroxidation and cell death in vitro by blocking lipid peroxide accumulation (Yang et al., 2025, DOI:10.1126/sciadv.adx6587).
• In conditional kidney-specific Gpx4 knockout mice, Liproxstatin-1 treatment significantly prolongs survival and reduces renal damage (Yang et al., 2025, DOI:10.1126/sciadv.adx6587).
• It reduces tissue damage in hepatic ischemia/reperfusion injury models, indicating broad applicability in tissue injury research (APExBIO, product page).
• Liproxstatin-1 is insoluble in water but dissolves at ≥10.5 mg/mL in DMSO and ≥2.39 mg/mL in ethanol with gentle warming and ultrasound (APExBIO, product page).
• Short-term storage at -20°C is recommended to maintain solution stability (APExBIO, product page).
• Compared to other ferroptosis inhibitors, Liproxstatin-1 demonstrates superior selectivity and efficacy in models with compromised redox defense (Liproxstatin-1: Advancing Ferroptosis Research...; this article expands with in vivo survival data).

Applications, Limits & Misconceptions

Liproxstatin-1 is widely used as a molecular probe for dissecting the lipid peroxidation pathway in ferroptosis research. Its high selectivity is critical for modeling iron-dependent cell death in GPX4-deficient systems, renal failure, and hepatic injury models. The compound is also applied in studies of neurodegeneration and cancer, where ferroptosis contributes to pathophysiology (Liproxstatin-1: Potent Ferroptosis Inhibitor with IC50 22 nM; this article clarifies boundaries for effective use).

Common Pitfalls or Misconceptions

• Liproxstatin-1 is not a universal cytoprotectant; it does not prevent apoptosis or necroptosis.
• Its efficacy is limited in models where cell death is not driven by lipid peroxidation.
• Incorrect solvent use (e.g., aqueous buffers) results in poor solubility and loss of activity.
• Long-term stock solutions are unstable, risking degradation and decreased efficacy.
• Overinterpretation of results can occur if proper ferroptosis-specific controls are not included.

Workflow Integration & Parameters

Researchers should prepare Liproxstatin-1 stock solutions at concentrations ≥10.5 mg/mL in DMSO or ≥2.39 mg/mL in ethanol, using gentle warming and ultrasound to facilitate dissolution (APExBIO). Solutions must be aliquoted and stored at -20°C for short-term use to maintain chemical integrity. Application concentrations in cell culture typically range from 10 to 500 nM, depending on model sensitivity and experimental endpoint. For in vivo studies, dosing should be based on established preclinical protocols, with vehicle and negative controls included. For further guidance on experimental deployment and advanced modeling strategies, see Liproxstatin-1: Potent Ferroptosis Inhibitor for Experime... (this article provides updated benchmarks and workflow cautions).

Conclusion & Outlook

Liproxstatin-1, supplied by APExBIO, is a benchmark tool for ferroptosis research, offering high specificity and nanomolar potency for dissecting the lipid peroxidation pathway. This compound has enabled key advances in understanding iron-dependent cell death and its impact on tissue injury and disease. Ongoing research is expected to further exploit Liproxstatin-1 for mechanism-based drug discovery and therapeutic innovation. For detailed specifications or ordering information, refer to the official product page.